Skip to main content

Dan German Blazer III, MD

Publications

Landa, K., V. Chandramohan, M. Gonen, J. M. Winter, M. Lidsky, K. Shah, S. Zani, et al. “CD226 Expression is Associated with Increased Survival in Pancreatic Cancer.” In Annals of Surgical Oncology, 27:S128–S128. SPRINGER, 2020.

Scholars@Duke

Moris, D. P., M. Cerullo, D. Nussbaum, and D. G. Blazer. “Textbook Outcomes Among Patients Undergoing Retroperitoneal Sarcoma Resection.” In Annals of Surgical Oncology, 27:S193–94. SPRINGER, 2020.

Scholars@Duke

Tsai, Catherine, Alexandra Mueller, Johannes Maubach, Rene Warschkow, Daniel P. Nussbaum, Bruno M. Schmied, Dan Blazer, Beat Gloor, and Mathias Worni. “No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.” Dig Surg 37, no. 3 (2020): 249–57. https://doi.org/10.1159/000501678.

Full Text

Lee, J. W., D. M. Cardona, D. G. Blazer, and D. G. Kirsch. “Response to Central Boost Radiation Therapy in an Unresectable Retroperitoneal Sarcoma: A Case Report.” Advances in Radiation Oncology, January 1, 2020. https://doi.org/10.1016/j.adro.2020.05.012.

Full Text

Kerr, David L., Brian L. Dial, Alexander L. Lazarides, Anthony A. Catanzano, Whitney O. Lane, Dan G. Blazer, Brian E. Brigman, Sergio Mendoza-Lattes, William C. Eward, and Melissa E. Erickson. “Epidemiologic and survival trends in adult primary bone tumors of the spine.” Spine J 19, no. 12 (December 2019): 1941–49. https://doi.org/10.1016/j.spinee.2019.07.003.

Full Text

Elizabeth McCracken, Emily K., Gregory P. Samsa, Deborah A. Fisher, Norma E. Farrow, Karenia Landa, Kevin N. Shah, Dan G. Blazer, and Sabino Zani. “Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer.” Hpb (Oxford) 21, no. 12 (December 2019): 1667–75. https://doi.org/10.1016/j.hpb.2019.03.365.

Full Text

Schmitz, Robin, Mohamed A. Adam, and Dan G. Blazer. “Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.” World J Surg Oncol 17, no. 1 (November 4, 2019): 180. https://doi.org/10.1186/s12957-019-1728-z.

Full Text

Kent, C. L., D. Marin, D. Niedzwiecki, S. J. Stephens, E. Duffy, M. Malicki, J. Abbruzzese, et al. “Imaging & Biomarker Correlates on Outcomes in a Phase II Trial of Neoadjuvant Gemcitabine/Nab-Paclitaxel and Hypofractionated Image-Guided Radiotherapy (HIGRT) in Potentially Resectable Pancreas Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 105:E238–39. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2014.

Full Text

Mao, Rui, Hong Zhao, Kan Li, Sheng Luo, Megan Turner, Jian-Qiang Cai, and Dan Blazer. “Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.” Ann Surg Oncol 26, no. 9 (September 2019): 2722–29. https://doi.org/10.1245/s10434-019-07506-5.

Full Text

Pages